Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Pharma MES 2025Pharma MES 2025
Not Confirmed
Not Confirmed
10-11 October, 2025
Not Confirmed
Not Confirmed
11-14 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Pharma MES 2025Pharma MES 2025
Industry Trade Show
Not Confirmed
10-11 October, 2025
Industry Trade Show
Not Confirmed
11-14 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
29 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/coya-therapeutics-announces-completion-of-patient-enrollment-of-an-investigator-initiated-open-label-study-with-low-dose-il-2-and-ctla4-ig-combination-treatment-in-patients-with-mild-to-moderate-frontotemporal-dementia-302568487.html
22 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/coya-therapeutics-launches-the-alstars-trial-a-phase-2-clinical-study-to-assess-the-efficacy-and-safety-of-coya-302-in-amyotrophic-lateral-sclerosis-302562369.html
16 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/coya-therapeutics-coya-303-shows-promising-central-nervous-system-cns-anti-inflammatory-effects-and-systemic-regulatory-t-cell-treg-enhancing-effects-in-a-preclinical-animal-inflammation-model-302556644.html
03 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/coya-therapeutics-to-participate-at-upcoming-september-investor-conferences-302544869.html
25 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/coya-therapeutics-announces-fda-acceptance-of-investigational-new-drug-ind-application-for-coya-302-for-the-treatment-of-amyotrophic-lateral-sclerosis-als-302537194.html
18 Aug 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/neurizon-becomes-second-biotech-hit-fda-delay-als-candidate
ABOUT THIS PAGE